The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIX.q

Neutrophilic dermatosis (Pyoderma, Sweet syndrome)

Publications

Sivanandam LK, Begum B, Martinez EC, Garikipati S, Sanker V, Siddiq A

Azathioprine hypersensitivity: A Sweet-like syndrome.

International journal of rheumatic diseases 2023 Jul 04;; — 2023 Jul 04

Arun Kumar AU, Elsayed ME, Alghali A, Ali AA, Mohamed H, Hussein W, Hackett C, Leonard N, Stack AG

Sweet syndrome: a rare feature of ANCA-associated vasculitis or unusual consequence of azathioprine-induced treatment.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2018;14;46 — 2018 — 46

El-Azhary RA, Brunner KL, Gibson LE

Sweet syndrome as a manifestation of azathioprine hypersensitivity.

Mayo Clinic proceedings 2008 Sep;83;1026-30 — 2008 Sep — 1026-30